terrestrial
123 employees on LinkedIn · 3 known investors
Terrestrial is developing the Tacterra microarray patch (MAP) platform, which uses dissolvable tips made from biomaterials to deliver therapies such as GLP-1 through the skin without injections. The platform is designed for patient self-administration at home or while traveling, removing the need for sharps and refrigeration.
Founders & leadership
RS
Rachel ShainCEO
Investors · 3
Competitors · 1
by search overlapCompanies competing with terrestrial for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does terrestrial do?
- Terrestrial is developing the Tacterra microarray patch (MAP) platform, which uses dissolvable tips made from biomaterials to deliver therapies such as GLP-1 through the skin without injections. The platform is designed for patient self-administration at home or while traveling, removing the need for sharps and refrigeration.
- Who are terrestrial's investors?
- terrestrial's investors include RA Capital, The Engine Ventures, Ulu Ventures.


